Drugs & Pharmaceuticals

This year’s influenza (“flu”) season, which has already begun in some parts of the country, revs up in November, and last until spring, will be made more ominous than ever by the current high numbers of COVID-19 cases in many parts of the nation.&

As Professor Katherine Seley-Radtke (1) and I wrote last July in an op

Why are so many Americans unwilling to get a COVID-19 vaccine?

Remember back in the early days of COVID when we knew little about the disease and had nothing to treat it with? Remdesivir (brand name Veklury®) seemed promising for a while, but as I wrote last year:

The race to discover anti-COVID drugs, just like the race to discover any drugs, has been long (1) and frustrating.

I'm sure seeing a lot of vaccine disquietude going around in the past few months.

April Fool's Day is seven months away. Otherwise, I'm betting that most of you would write this off as just another joke article. Don't.

Ivermectin is a wonderful drug. So effective that its discovery deserved the 2015 Nobel Prize in Medicine and Physiology awarded to Japanese chemist Satoshi Omura and American parasitologist William Campbell.

Back in February, when I got my second Covid shot in Manhattan, I never would have guessed that I'd be heading over to CVS for a booster. But that's just what happened last week.

“A groundbreaking preprint paper by the prestigious Oxford University Clinical Research Group … includes alarming findings devastating to the COVID vaccine rollout,” Children's Health Defense (CHD)